Antigenic targets in clear cell renal cell carcinoma

被引：2

作者：

Schindler, Nicholas R. ^{[1
,2
]}

Braun, David A. ^{[1
,2
]}

机构：

[1] Yale Sch Med, Dept Internal Med, Sect Med Oncol, New Haven, CT USA

[2] Yale Sch Med, Yale Canc Ctr, Ctr Mol & Cellular Oncol, New Haven, CT USA

来源：

KIDNEY CANCER | 2023年 / 7卷 / 01期

关键词：

Renal cell carcinoma; tumor antigen; neoantigen; cancer vaccine; T cell receptor; chimeric antigen receptor T cell; TUMOR-INFILTRATING LYMPHOCYTES; CYTOLYTIC T-LYMPHOCYTES; SELECTIVE EXPRESSION; 1ST-LINE THERAPY; CANCER VACCINE; MELANOMA; NEOANTIGENS; SUNITINIB; RESPONSES; IMA901;

D O I：

10.3233/KCA-230006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Immune checkpoint inhibitors (ICIs) have transformed the management of advanced renal cell carcinoma (RCC), but most patients still do not receive a long-term benefit from these therapies, and many experience off-target, immune-related adverse effects. RCC is also different from many other ICI-responsive tumors, as it has only a modest mutation burden, and total neoantigen load does not correlate with ICI response. In order to improve the efficacy and safety of immunotherapies for RCC, it is therefore critical to identify the antigens that are targeted in effective anti-tumor immunity. In this review, we describe the potential classes of target antigens, and provide examples of previous and ongoing efforts to investigate and target antigens in RCC, with a focus on clear cell histology. Ultimately, we believe that a concerted antigen discovery effort in RCC will enable an improved understanding of response and resistance to current therapies, and lay a foundation for the future development of "precision" antigen-directed immunotherapies.

引用

页码：81 / 91

页数：11

共 82 条

[1] The opposing roles of CD4+ T cells in anti-tumour immunity [J].

Ahrends, Tomasz ;

Borst, Jannie .

IMMUNOLOGY, 2018, 154 (04) :582-592

[2] Signatures of mutational processes in human cancer [J].

Alexandrov, Ludmil B. ;

Nik-Zainal, Serena ;

Wedge, David C. ;

Aparicio, Samuel A. J. R. ;

Behjati, Sam ;

Biankin, Andrew V. ;

Bignell, Graham R. ;

Bolli, Niccolo ;

Borg, Ake ;

Borresen-Dale, Anne-Lise ;

Boyault, Sandrine ;

Burkhardt, Birgit ;

Butler, Adam P. ;

Caldas, Carlos ;

Davies, Helen R. ;

Desmedt, Christine ;

Eils, Roland ;

Eyfjord, Jorunn Erla ;

Foekens, John A. ;

Greaves, Mel ;

Hosoda, Fumie ;

Hutter, Barbara ;

Ilicic, Tomislav ;

Imbeaud, Sandrine ;

Imielinsk, Marcin ;

Jaeger, Natalie ;

Jones, David T. W. ;

Jones, David ;

Knappskog, Stian ;

Kool, Marcel ;

Lakhani, Sunil R. ;

Lopez-Otin, Carlos ;

Martin, Sancha ;

Munshi, Nikhil C. ;

Nakamura, Hiromi ;

Northcott, Paul A. ;

Pajic, Marina ;

Papaemmanuil, Elli ;

Paradiso, Angelo ;

Pearson, John V. ;

Puente, Xose S. ;

Raine, Keiran ;

Ramakrishna, Manasa ;

Richardson, Andrea L. ;

Richter, Julia ;

Rosenstiel, Philip ;

Schlesner, Matthias ;

Schumacher, Ton N. ;

Span, Paul N. ;

Teague, Jon W. .

NATURE, 2013, 500 (7463) :415-+

[3] T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma-Implications for Adoptive Cell Therapy [J].

Andersen, Rikke ;

Westergaard, Marie Christine Wulff ;

Kjeldsen, Julie Westerlin ;

Mueller, Anja ;

Pedersen, Natasja Wulff ;

Hadrup, Sine Reker ;

Met, Ozcan ;

Seliger, Barbara ;

Kromann-Andersen, Bjarne ;

Hasselager, Thomas ;

Donia, Marco ;

Svane, Inge Marie .

CANCER IMMUNOLOGY RESEARCH, 2018, 6 (02) :222-235

[4] Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma [J].

Andersen, Rikke ;

Donia, Marco ;

Westergaard, Marie Christine Wulff ;

Pedersen, Magnus ;

Hansen, Morten ;

Svane, Inge Marie .

HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (12) :2790-2795

[5] High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993 [J].

Atkins, MB ;

Lotze, MT ;

Dutcher, JP ;

Fisher, RI ;

Weiss, G ;

Margolin, K ;

Abrams, J ;

Sznol, M ;

Parkinson, D ;

Hawkins, M ;

Paradise, C ;

Kunkel, L ;

Rosenberg, SA .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :2105-2116

[6] Human endogenous retroviruses and their implication for immunotherapeutics of cancer [J].

Attermann, A. S. ;

Bjerregaard, A-M ;

Saini, S. K. ;

Gronbaek, K. ;

Hadrup, S. R. .

ANNALS OF ONCOLOGY, 2018, 29 (11) :2183-2191

[7] Efficient and reproducible generation of tumour-infiltrating lymphocytes for renal cell carcinoma [J].

Baldan, V. ;

Griffiths, R. ;

Hawkins, R. E. ;

Gilham, D. E. .

BRITISH JOURNAL OF CANCER, 2015, 112 (09) :1510-1518

[8] HERVs New Role in Cancer: From Accused Perpetrators to Cheerful Protectors [J].

Bannert, Norbert ;

Hofmann, Henning ;

Block, Adriana ;

Hohn, Oliver .

FRONTIERS IN MICROBIOLOGY, 2018, 9

[9] Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients [J].

Berinstein, Neil L. ;

Karkada, Mohan ;

Oza, Amit M. ;

Odunsi, Kunle ;

Villella, Jeannine A. ;

Nemunaitis, John J. ;

Morse, Michael A. ;

Pejovic, Tanja ;

Bentley, James ;

Buyse, Marc ;

Nigam, Rita ;

Weir, Genevieve M. ;

MacDonald, Lisa D. ;

Quinton, Tara ;

Rajagopalan, Rajkannan ;

Sharp, Kendall ;

Penwell, Andrea ;

Sammatur, Leeladhar ;

Burzykowski, Tomasz ;

Stanford, Marianne M. ;

Mansour, Marc .

ONCOIMMUNOLOGY, 2015, 4 (08)

[10] Defining 'T cell exhaustion' [J].

Blank, Christian U. ;

Haining, W. Nicholas ;

Held, Werner ;

Hogan, Patrick G. ;

Kallies, Axel ;

Lugli, Enrico ;

Lynn, Rachel C. ;

Philip, Mary ;

Rao, Anjana ;

Restifo, Nicholas P. ;

Schietinger, Andrea ;

Schumacher, Ton N. ;

Schwartzberg, Pamela L. ;

Sharpe, Arlene H. ;

Speiser, Daniel E. ;

Wherry, E. John ;

Youngblood, Benjamin A. ;

Zehn, Dietmar .

NATURE REVIEWS IMMUNOLOGY, 2019, 19 (11) :665-674

← 1 2 3 4 5 6 7 8 9 →